About Jianqing Li
Form D filings for Bluejay Therapeutics in 2024 list Jianqing Li as director.
Jianqing Li first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jianqing Li in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jianqing Li works with at each company, as listed on that company's latest Form D.
Bluejay Therapeutics, Inc. · Form D, May 10, 2024
DE
Dan Estes
Director
PK
Pascal Krotee
Director
KC
Keting Chu
Chief Executive Officer and director
AL
Alon Lazarus
Director
DY
Dajun Yang
Director